- Home
- PRLD vs TORO Comparison
PRLD vs TORO Comparison
Compare PRLD & TORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- TORO
- Stock Information
- Founded
- PRLD 2016
- TORO 2022
- Country
- PRLD United States
- TORO Cyprus
- Employees
- PRLD N/A
- TORO N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- TORO Marine Transportation
- Sector
- PRLD Health Care
- TORO Consumer Discretionary
- Exchange
- PRLD Nasdaq
- TORO Nasdaq
- Market Cap
- PRLD 69.1M
- TORO 78.4M
- IPO Year
- PRLD 2020
- TORO N/A
- Fundamental
- Price
- PRLD $1.58
- TORO $3.79
- Analyst Decision
- PRLD Strong Buy
- TORO
- Analyst Count
- PRLD 3
- TORO 0
- Target Price
- PRLD $4.00
- TORO N/A
- AVG Volume (30 Days)
- PRLD 258.3K
- TORO 115.3K
- Earning Date
- PRLD 10-31-2025
- TORO 11-14-2025
- Dividend Yield
- PRLD N/A
- TORO N/A
- EPS Growth
- PRLD N/A
- TORO N/A
- EPS
- PRLD N/A
- TORO 0.01
- Revenue
- PRLD $7,000,000.00
- TORO $20,143,992.00
- Revenue This Year
- PRLD N/A
- TORO N/A
- Revenue Next Year
- PRLD N/A
- TORO N/A
- P/E Ratio
- PRLD N/A
- TORO $302.46
- Revenue Growth
- PRLD N/A
- TORO 0.40
- 52 Week Low
- PRLD $0.61
- TORO $1.70
- 52 Week High
- PRLD $1.91
- TORO $4.94
- Technical
- Relative Strength Index (RSI)
- PRLD 57.91
- TORO 51.16
- Support Level
- PRLD $1.49
- TORO $3.76
- Resistance Level
- PRLD $1.72
- TORO $4.19
- Average True Range (ATR)
- PRLD 0.17
- TORO 0.17
- MACD
- PRLD 0.02
- TORO -0.08
- Stochastic Oscillator
- PRLD 75.44
- TORO 4.76
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.